Back to Search
Start Over
A patient-derived cell model for malignant transformation in IDH-mutant glioma.
- Source :
-
Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Sep 10; Vol. 12 (1), pp. 148. Date of Electronic Publication: 2024 Sep 10. - Publication Year :
- 2024
-
Abstract
- Malignant transformation (MT) is commonly seen in IDH-mutant gliomas. There has been a growing research interest in revealing its underlying mechanisms and intervening prior to MT at the early stages of the transforming process. Here we established a unique pair of matched 3D cell models: 403L, derived from a low-grade glioma (LGG), and 403H, derived from a high-grade glioma (HGG), by utilizing IDH-mutant astrocytoma samples from the same patient when the tumor was diagnosed as WHO grade 2 (tumor mutational burden (TMB) of 3.96/Mb) and later as grade 4 (TMB of 70.07/Mb), respectively. Both cell models were authenticated to a patient's sample retaining endogenous expression of IDH1 R132H. DNA methylation profiles of the parental tumors referred to LGG and HGG IDH-mutant glioma clusters. The immunopositivity of SOX2, NESTIN, GFAP, OLIG2, and beta 3-Tubulin suggested the multilineage potential of both models. 403H was more prompt to cell invasion and developed infiltrative HGG in vivo. The differentially expressed genes (DEGs) from the RNA sequencing analysis revealed the tumor invasion and aggressiveness related genes exclusively upregulated in the 403H model. Pathway analysis showcased an enrichment of genes associated with epithelial-mesenchymal transition (EMT) and Notch signaling pathways in 403H and 403L, respectively. Mass spectrometry-based targeted metabolomics and hyperpolarized (HP) 1- <superscript>13</superscript> C pyruvate in-cell NMR analyses demonstrated significant alterations in the TCA cycle and fatty acid metabolism. Citrate, glutamine, and 2-HG levels were significantly higher in 403H. To our knowledge, this is the first report describing the development of a matched pair of 3D patient-derived cell models representative of MT and temozolomide (TMZ)-induced hypermutator phenotype (HMP) in IDH-mutant glioma, providing insights into genetic and metabolic changes during MT/HMP. This novel in vitro model allows further investigation of the mechanisms of MT at the cellular level.<br /> (© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.)
- Subjects :
- Humans
Animals
Isocitrate Dehydrogenase genetics
Isocitrate Dehydrogenase metabolism
Glioma genetics
Glioma pathology
Glioma metabolism
Brain Neoplasms genetics
Brain Neoplasms pathology
Brain Neoplasms metabolism
Cell Transformation, Neoplastic genetics
Cell Transformation, Neoplastic pathology
Cell Transformation, Neoplastic metabolism
Mutation
Subjects
Details
- Language :
- English
- ISSN :
- 2051-5960
- Volume :
- 12
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Acta neuropathologica communications
- Publication Type :
- Academic Journal
- Accession number :
- 39256867
- Full Text :
- https://doi.org/10.1186/s40478-024-01860-6